Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.270
+0.172 (8.20%)
Mar 13, 2025, 1:32 PM CET
Nykode Therapeutics AS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -38.82 | -35.15 | -42.74 | -9.41 | 149.77 | Upgrade
|
| Depreciation & Amortization | 2.25 | 2.12 | 1.81 | 0.73 | 0.3 | Upgrade
|
| Stock-Based Compensation | 3.79 | 3.7 | 3.83 | 3.44 | 2.6 | Upgrade
|
| Other Operating Activities | -9.29 | -22.41 | -9.5 | -1.62 | 32.96 | Upgrade
|
| Change in Accounts Receivable | 1.41 | -26.59 | 22.43 | -7.17 | -19.46 | Upgrade
|
| Change in Accounts Payable | -2.56 | -2.77 | 2.28 | -0.66 | 6.85 | Upgrade
|
| Change in Unearned Revenue | -7.99 | -15.5 | 6.09 | 17.78 | 1.8 | Upgrade
|
| Change in Other Net Operating Assets | -0 | -0.03 | -4.89 | -1.94 | 5.46 | Upgrade
|
| Operating Cash Flow | -51.22 | -96.62 | -20.69 | 1.16 | 180.27 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -99.36% | - | Upgrade
|
| Capital Expenditures | -0.07 | -1.9 | -2.68 | -0.87 | -0.1 | Upgrade
|
| Investment in Securities | - | - | 10.04 | 11.35 | -5.93 | Upgrade
|
| Other Investing Activities | 7 | 8.94 | 3.68 | 0.27 | 0.01 | Upgrade
|
| Investing Cash Flow | 6.93 | 7.04 | 11.05 | 10.75 | -6.02 | Upgrade
|
| Long-Term Debt Repaid | -1.22 | -0.89 | -1.2 | -0.61 | -0.24 | Upgrade
|
| Net Debt Issued (Repaid) | -1.22 | -0.89 | -1.2 | -0.61 | -0.24 | Upgrade
|
| Issuance of Common Stock | - | 45.7 | 1.8 | 21.18 | - | Upgrade
|
| Other Financing Activities | -0.18 | -0.22 | -0.24 | -0.13 | -0.05 | Upgrade
|
| Financing Cash Flow | -1.4 | 44.59 | 0.36 | 20.44 | -0.29 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.52 | 1.21 | -0.56 | 0.03 | -0.27 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | 0 | Upgrade
|
| Net Cash Flow | -47.2 | -43.78 | -9.85 | 32.38 | 173.69 | Upgrade
|
| Free Cash Flow | -51.29 | -98.53 | -23.37 | 0.28 | 180.17 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -99.84% | - | Upgrade
|
| Free Cash Flow Margin | -560.07% | -739.52% | -258.81% | 0.79% | 83.53% | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.33 | -0.08 | 0.00 | 0.61 | Upgrade
|
| Cash Interest Paid | 0.18 | 0.22 | 0.24 | 0.13 | 0.05 | Upgrade
|
| Levered Free Cash Flow | -34.3 | -49.62 | -8.6 | 6.38 | 103.92 | Upgrade
|
| Unlevered Free Cash Flow | -34.18 | -49.48 | -8.45 | 6.46 | 103.95 | Upgrade
|
| Change in Net Working Capital | 9.94 | 16.27 | -29.79 | -9.89 | 10.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.